BioCentury
ARTICLE | Company News

Inhibitex, University of Georgia Research Foundation deal

September 17, 2007 7:00 AM UTC

The university granted INHX exclusive, worldwide rights to a series of HIV integrase inhibitors and HCV polymerase inhibitors. INHX plans to begin preclinical testing of an HIV integrase inhibitor ne...